Article Information
History
- March 27, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Atsushi Gotoa,*,#,
- Kei Miyakawab,#,
- Izumi Nakayamaa,
- Susumu Yagomea,c,
- Juan Xud,
- Makoto Kanekoa,
- Norihisa Ohtakee,f,
- Hideaki Katog and
- Akihide Ryob
- aDepartment of Health Data Science, Graduate School of Data Science, Yokohama City University 22-2 Seto, Kanazawa-ku, Yokohama 236-0027, Japan
- bDepartment of Microbiology, Graduate School of Medicine, Yokohama City University, 3-9 Fukuura, Kanazawa-ku, Yokohama 236-0004, Japan
- cIntegrity Healthcare Co., Ltd., 1-27-5 Nihonbashikakigaracho, Chuo-ku, 103-0014 Tokyo, Japan
- dDepartment of Endocrinology and Metabolism, Graduate School of Medicine, Yokohama-City University, 3-9 Fukuura, Kanazawa-ku, Yokohama, Japan
- eBioscience Division, Research & Development Department, Tosoh Corporation, Tokyo research center, 2743-1 Hayakawa, Ayase-shi, Kanagawa 252-1123, Japan
- fAdvanced Medical Research Center, Yokohama City University, 3-9 Fukuura, Kanazawa-ku, Yokohama 236-0004, Japan
- gInfection Prevention and Control Department, Yokohama City University Hospital, 3-9 Fukuura, Kanazawa-ku, Yokohama 236-0004, Japan
- ↵*Corresponding Author, Atushi Goto, MD, PhD, MPH Address: 22-2 Seto, Kanazawa-ku, Yokohama, Japan, 236-0027 Tel.: +81-45-787-2215 E-mail: agoto{at}yokohama-cu.ac.jp
↵# These authors contributed equally to this work.
Posted March 27, 2022.
Analysis of humoral immunity against emerging SARS-CoV-2 variants: a population-based prevalence study in Yokohama, Japan
